▶ 調査レポート

世界の胃食道逆流症（GERD）治療薬市場：市場規模・現状・予測
• 英文タイトル：Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界の胃食道逆流症（GERD）治療薬市場：市場規模・現状・予測 / Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size, Status and Forecast 2019-2025 / QYR9N7228資料のイメージです。• レポートコード：QYR9N7228
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ
• 販売価格（消費税別）
  Single User￥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License￥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当資料は、胃食道逆流症（GERD）治療薬のグローバル市場について調査・分析したレポートで、種類別（制酸剤、運動促進剤、H2受容体ブロッカー、プロトンポンプ阻害剤（PPI））、用途別（胸焼け、酸逆流障害）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・胃食道逆流症（GERD）治療薬の世界市場規模
・主要企業別市場シェア
・胃食道逆流症（GERD）治療薬の世界市場規模：種類別（制酸剤、運動促進剤、H2受容体ブロッカー、プロトンポンプ阻害剤（PPI））
・胃食道逆流症（GERD）治療薬の世界市場規模：用途別（胸焼け、酸逆流障害）
・胃食道逆流症（GERD）治療薬のアメリカ市場規模（種類別、用途別）
・胃食道逆流症（GERD）治療薬のヨーロッパ市場規模（種類別、用途別）
・胃食道逆流症（GERD）治療薬の中国市場規模（種類別、用途別）
・胃食道逆流症（GERD）治療薬の日本市場規模（種類別、用途別）
・胃食道逆流症（GERD）治療薬の東南アジア市場規模（種類別、用途別）
・胃食道逆流症（GERD）治療薬のインド市場規模（種類別、用途別）
・胃食道逆流症（GERD）治療薬の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・胃食道逆流症（GERD）治療薬の世界市場予測（2019年-2025年）
・胃食道逆流症（GERD）治療薬の地域別市場予測（2019年-2025年）
...

Gastroesophageal reflux disease (GERD), also known as acid reflux, is a long-term condition where stomach contents come back up into the esophagus resulting in either symptoms or complications.Patent expiry of blockbuster drugs prescribed for the treatment of acid reflux disorders is majorly attributable for the downfall of this market.
In 2018, the global Gastroesophageal Reflux Disease (GERD) Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Gastroesophageal Reflux Disease (GERD) Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gastroesophageal Reflux Disease (GERD) Therapeutics development in United States, Europe and China.

The key players covered in this study
AstraZeneca
Eisai
GSK
Takeda
Johnson & Johnson
…

Market segment by Type, the product can be split into
Antacids
Pro-kinetic agents
H2 Receptor Blockers
Proton Pump Inhibitors (PPIs)

Market segment by Application, split into
Heartburn
Acid reflux disorders

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Gastroesophageal Reflux Disease (GERD) Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Gastroesophageal Reflux Disease (GERD) Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Gastroesophageal Reflux Disease (GERD) Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Antacids
1.4.3 Pro-kinetic agents
1.4.4 H2 Receptor Blockers
1.4.5 Proton Pump Inhibitors (PPIs)
1.5 Market by Application
1.5.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application (2014-2025)
1.5.2 Heartburn
1.5.3 Acid reflux disorders
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size
2.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Growth Trends by Regions
2.2.1 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Regions (2014-2025)
2.2.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Manufacturers
3.1.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players Head office and Area Served
3.3 Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Product/Solution/Service
3.4 Date of Enter into Gastroesophageal Reflux Disease (GERD) Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2014-2019)
4.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2014-2019)
5.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players in United States
5.3 United States Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type
5.4 United States Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application

6 Europe
6.1 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2014-2019)
6.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players in Europe
6.3 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type
6.4 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application

7 China
7.1 China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2014-2019)
7.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players in China
7.3 China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type
7.4 China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application

8 Japan
8.1 Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2014-2019)
8.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players in Japan
8.3 Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type
8.4 Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2014-2019)
9.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type
9.4 Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application

10 India
10.1 India Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2014-2019)
10.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players in India
10.3 India Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type
10.4 India Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size (2014-2019)
11.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Key Players in Central & South America
11.3 Central & South America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type
11.4 Central & South America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application

12 International Players Profiles
12.1 AstraZeneca
12.1.1 AstraZeneca Company Details
12.1.2 Company Description and Business Overview
12.1.3 Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
12.1.4 AstraZeneca Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2014-2019)
12.1.5 AstraZeneca Recent Development
12.2 Eisai
12.2.1 Eisai Company Details
12.2.2 Company Description and Business Overview
12.2.3 Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
12.2.4 Eisai Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2014-2019)
12.2.5 Eisai Recent Development
12.3 GSK
12.3.1 GSK Company Details
12.3.2 Company Description and Business Overview
12.3.3 Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
12.3.4 GSK Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2014-2019)
12.3.5 GSK Recent Development
12.4 Takeda
12.4.1 Takeda Company Details
12.4.2 Company Description and Business Overview
12.4.3 Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
12.4.4 Takeda Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2014-2019)
12.4.5 Takeda Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Company Details
12.5.2 Company Description and Business Overview
12.5.3 Gastroesophageal Reflux Disease (GERD) Therapeutics Introduction
12.5.4 Johnson & Johnson Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2014-2019)
12.5.5 Johnson & Johnson Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Gastroesophageal Reflux Disease (GERD) Therapeutics Key Market Segments
Table Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Covered
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Market Share by Type 2014-2025
Figure Antacids Figures
Table Key Players of Antacids
Figure Pro-kinetic agents Figures
Table Key Players of Pro-kinetic agents
Figure H2 Receptor Blockers Figures
Table Key Players of H2 Receptor Blockers
Figure Proton Pump Inhibitors (PPIs) Figures
Table Key Players of Proton Pump Inhibitors (PPIs)
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Heartburn Case Studies
Figure Acid reflux disorders Case Studies
Figure Gastroesophageal Reflux Disease (GERD) Therapeutics Report Years Considered
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Regions 2014-2019
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Regions 2014-2019
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Manufacturers in 2018
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Product/Solution/Service
Table Date of Enter into Gastroesophageal Reflux Disease (GERD) Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Share by Type (2014-2019)
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Share by Application (2014-2019)
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Application in 2018
Figure United States Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share (2018-2019)
Table United States Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Type (2014-2019)
Table United States Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application (2014-2019)
Figure Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share (2018-2019)
Table Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Type (2014-2019)
Table Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application (2014-2019)
Figure China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share (2018-2019)
Table China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Type (2014-2019)
Table China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application (2014-2019)
Figure Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share (2018-2019)
Table Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Type (2014-2019)
Table Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share (2018-2019)
Table Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application (2014-2019)
Figure India Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share (2018-2019)
Table India Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Type (2014-2019)
Table India Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share (2018-2019)
Table Central & South America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Type (2014-2019)
Table Central & South America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share by Application (2014-2019)
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2014-2019) (Million US$)
Figure AstraZeneca Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2014-2019)
Table AstraZeneca Recent Development
Table Eisai Company Details
Table Eisai Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2014-2019)(Million US$)
Figure Eisai Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2014-2019)
Table Eisai Recent Development
Table GSK Company Details
Table GSK Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2014-2019)(Million US$)
Figure GSK Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2014-2019)
Table GSK Recent Development
Table Takeda Company Details
Table Takeda Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2014-2019)(Million US$)
Figure Takeda Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2014-2019)
Table Takeda Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Gastroesophageal Reflux Disease (GERD) Therapeutics Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Share by Regions in 2025
Figure United States Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Product (2019-2025)
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Product in 2025
Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application (2019-2025)
Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界の胃食道逆流症（GERD）デバイス市場：市場規模・現状・予測
    Global Gastroesophageal Reflux Disease (GERD) Devices Market Size, Status and Forecast 2019-2025
    QYR9N7227 2019年6月14日 95Pages
    当資料は、胃食道逆流症（GERD）デバイスのグローバル市場について調査・分析したレポートで、種類別（診断装置、治療装置）、用途別（病院、診療所、外来手術センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界のGERD＆NERD治療市場：市場規模・現状・予測
    Global GERD & NERD Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7237 2019年6月14日 105Pages
    当資料は、GERD＆NERD治療のグローバル市場について調査・分析したレポートで、種類別（制酸剤（酸中和剤）、プロトンポンプ阻害剤、H2受容体ブロッカー）、用途別（病院と診療所、研究センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関...
  • 世界の逆流性腎症の治療市場：市場規模・現状・予測
    Global Reflux Nephropathy Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7943 2019年6月14日 98Pages
    当資料は、逆流性腎症の治療のグローバル市場について調査・分析したレポートで、種類別（予防用抗生物質、降圧薬、鎮痛剤、その他）、用途別（病院薬局、小売薬局、通販薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界の獣医感染症治療薬市場：市場規模・現状・予測
    Global Veterinary Infectious Disease Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9N8175 2019年6月14日 98Pages
    当資料は、獣医感染症治療薬のグローバル市場について調査・分析したレポートで、種類別（抗生物質、抗ウイルス薬、抗真菌、殺虫剤、駆虫薬）、用途別（獣医病院、獣医クリニック、獣医薬局、研究機関）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報な...
  • 世界の炎症性腸疾患（IBD）治療学市場：市場規模・現状・予測
    Global Inflammatory Bowel Disease (IBD) Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9N7361 2019年6月14日 96Pages
    当資料は、炎症性腸疾患（IBD）治療学のグローバル市場について調査・分析したレポートで、種類別（抗炎症バイオ医薬品、非ステロイド系抗炎症薬（NSAID）、コルチコステロイド）、用途別（病院、研究）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企...
  • 世界のクローン病治療薬市場：市場規模・現状・予測
    Global Crohn’s Disease Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9N7041 2019年6月14日 95Pages
    当資料は、クローン病治療薬のグローバル市場について調査・分析したレポートで、種類別（非外科的、外科的）、用途別（病院、外来手術センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・ク...
  • 世界のクッシング病治療市場：市場規模・現状・予測
    Global Cushing’s Disease Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7048 2019年6月14日 94Pages
    当資料は、クッシング病治療のグローバル市場について調査・分析したレポートで、種類別（ケトコナゾール、ミトタン、アミノグルテチミド、メチラポン、ミフェプリストン、その他）、用途別（病院薬局、小売薬局、ドラッグストア、診療所、Eコマース/オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東...
  • 世界のサンドホフ病治療薬市場2019
    Global Sandhoff Disease Therapeutics Sales Market Report 2019
    QYR9N4169 2019年6月13日 104Pages
    本調査レポートでは、サンドホフ病治療薬の世界市場について調査・分析し、サンドホフ病治療薬のメーカー別販売量、市場シェア分析、種類別販売分析（ALD-601
    、CCP-010
    、DUOC-01
    、MTf-HEXB
    、その他）、用途別販売分析（診療所、病院...
  • 世界のウィルソン病薬市場：市場規模・現状・予測
    Global Wilson's Disease Drugs Market Size, Status and Forecast 2019-2025
    QYR9N8198 2019年6月14日 93Pages
    当資料は、ウィルソン病薬のグローバル市場について調査・分析したレポートで、種類別（トリエンティン、D-ペニシラミン、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
    ...
  • 世界のまれな内分泌疾患の治療市場：市場規模・現状・予測
    Global Rare Endocrine Disease Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7936 2019年6月14日 94Pages
    当資料は、まれな内分泌疾患の治療のグローバル市場について調査・分析したレポートで、種類別（生物製剤、有機化合物）、用途別（病院薬局、オンライン薬局、小売薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。